August 27, 2026 | AI, AI pharma, AI tools, Compliant AI, Impetus Digital, QIP, Quality improvement programs, artificial intelligence, compliance, insight gathering, medical education, pharma insights, pharma teams, pharma webinar, training programs, virtual tools
See how top-tier pharma teams use compliant AI tools and virtual QIPs to capture real-time market intelligence, confidence scores, and audience insights from live dashboards

AI sounds great in theory, but very few pharma teams know how to integrate it meaningfully into their programs without creating extra friction, compliance headaches, or overspending on tech hype. Join us for our upcoming webinar Oct 14, 22, & 27, where we move beyond the buzz to explore how agile Medical Affairs, Med Ed, and Commercial teams are leveraging practical, compliant AI tools and virtual workflows to transform passive audiences into active, high-retention collaborators.
From conversational AI peers and dynamic AI-driven presentations to virtual Quality Improvement Programs (QIPs), discover how top pharma companies are boosting knowledge retention by 4x and capturing real-time market intelligence without enterprise price tags or operational complexity. The future isn’t about adopting AI for the sake of it; it’s about choosing the right tools to elevate your engagement strategies.
Real Client Case Studies: Explore actual workflows and outcomes where top pharma brands successfully deployed AI across diverse programs.
A Showcase of Next-Gen Tools: Get a firsthand look at dynamic AI presenters, interactive avatars, virtual QIP environments, and more in action.
The Business Case & ROI: Discover how to achieve 4x higher retention and maximum impact while keeping project budgets surprisingly manageable.
Frictionless & Safe Implementation: Learn the rigorous training guardrails that guarantee pharma compliance, audit readiness, and zero open-web risk.
Creative Use Cases & Best Practices: Uncover actionable strategies and tips to integrate AI across Med Ed, Medical Affairs, and Commercial launches.
This content was provided by Impetus Digital
Company Details
Latest Content from Impetus Digital
Hicham Naim, Global Head, Integrated & Personalized Patient Care Program, Digital Advisory Board at Takeda & Founder of Curated Health, explores digital medicine & biomarkers, outcomes-based business models, Software as…
The Impetus InSite Platform® can be used to facilitate virtual and hybrid engagement at all stages of the product lifecycle. Here, we share 10 of the most popular ways to…
The Honourable Tony Clement, Co-chair at Reshoring Canada and former Minister of Health, discusses digital transformation, the importance of onshore manufacturing and supply chain operations in Canada, current pharmaceutical regulatory…
Virtual engagement experts helping life science companies have ongoing conversations with their customers through our best-in-class online collaboration tools. Best-In-Class Collaboration Technology Impetus Digital provides two turn-key software solutions through…
Sara Aghvami, Director of Best Buy Health at Best Buy Canada, explores the concept of “helpful homes” and the role of digital health in enabling “aging in place.” She also…
Jennifer Helfer, Senior Director, Patient Advocacy & Engagement at Encoded Therapeutics Inc., discusses genomics-driven precision medicine, gene therapy misconceptions and fears, involving patients and caregivers in designing gene therapy trials,…
Rishi Nayyar, Co-founder & CEO of PocketHealth, explores how releasing medical imaging records straight to patients can result in data moving more ethically, easily, and securely. He also shares his…
Learn how we helped our client develop a virtual speaker program and roll out a series of regional peer-to-peer education sessions.
Dr. Tarry Ahuja, Manager of Program Development in Pharmaceutical Reviews and Senior RWE Advisor at CADTH, explores the impact of COVID-19 on the biopsychosocial model of health, key opportunities and…
In this episode of Impetus Digital’s Leaders in Pharma podcast, I sit down with Fran Milnes. She is currently the Head of Marketing and Commercial Excellence in Oncology at Novartis.
